Literature DB >> 33708644

Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains.

Katariina Koskinen1, Reetta Penttinen2, Anni-Maria Örmälä-Odegrip3, Christian G Giske3,4, Tarmo Ketola1, Matti Jalasvuori1.   

Abstract

Over the past few decades, extensively drug resistant (XDR) resistant Klebsiella pneumoniae has become a notable burden to healthcare all over the world. Especially carbapenemase-producing strains are problematic due to their capability to withstand even last resort antibiotics. Some sequence types (STs) of K. pneumoniae are significantly more prevalent in hospital settings in comparison to other equally resistant strains. This provokes the question whether or not there are phenotypic characteristics that may render certain K. pneumoniae more suitable for epidemic dispersal between patients, hospitals, and different environments. In this study, we selected seven epidemic and non-epidemic carbapenem resistant K. pneumoniae isolates for extensive systematic characterization for phenotypic and genotypic qualities in order to identify potential factors that precede or emerge from epidemic successfulness. Studied characteristics include growth rates and densities in different conditions (media, temperature, pH, resource levels), tolerance to alcohol and drought, inhibition between strains, ability to compensate pH, as well as various genomic features. Overall, there are clear differences between isolates, yet, only drought tolerance was found to notably associate with non-epidemic K. pneumoniae strains. We further report a preliminary study on the potential to control K. pneumoniae ST11 with an antimicrobial component produced by a non-epidemic K. pneumoniae. This component initially restricts bacterial growth, but stable resistance develops rapidly in vitro.
Copyright © 2021 Koskinen, Penttinen, Örmälä-Odegrip, Giske, Ketola and Jalasvuori.

Entities:  

Keywords:  XDR Klebsiella pneumoniae; antibiotic resistance; epidemic; extended-spectrum beta-lactamase; virulence

Mesh:

Substances:

Year:  2021        PMID: 33708644      PMCID: PMC7940544          DOI: 10.3389/fcimb.2021.599924

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  41 in total

1.  Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.

Authors:  M Vading; Ø Samuelsen; B Haldorsen; A S Sundsfjord; C G Giske
Journal:  Clin Microbiol Infect       Date:  2011-05       Impact factor: 8.067

2.  Increasing tolerance of hospital Enterococcus faecium to handwash alcohols.

Authors:  Sacha J Pidot; Wei Gao; Andrew H Buultjens; Ian R Monk; Romain Guerillot; Glen P Carter; Jean Y H Lee; Margaret M C Lam; M Lindsay Grayson; Susan A Ballard; Andrew A Mahony; Elizabeth A Grabsch; Despina Kotsanas; Tony M Korman; Geoffrey W Coombs; J Owen Robinson; Anders Gonçalves da Silva; Torsten Seemann; Benjamin P Howden; Paul D R Johnson; Timothy P Stinear
Journal:  Sci Transl Med       Date:  2018-08-01       Impact factor: 17.956

3.  Virulence genes in isolates of Klebsiella pneumoniae from the UK during 2016, including among carbapenemase gene-positive hypervirulent K1-ST23 and 'non-hypervirulent' types ST147, ST15 and ST383.

Authors:  Jane F Turton; Zoë Payne; Amy Coward; Katie L Hopkins; Jack A Turton; Michel Doumith; Neil Woodford
Journal:  J Med Microbiol       Date:  2017-12-05       Impact factor: 2.472

Review 4.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

5.  Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

Authors:  Brandon Kitchel; J Kamile Rasheed; Jean B Patel; Arjun Srinivasan; Shiri Navon-Venezia; Yehuda Carmeli; Alma Brolund; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

Review 6.  The epidemiology of nosocomial infections caused by Klebsiella pneumoniae.

Authors:  W R Jarvis; V P Munn; A K Highsmith; D H Culver; J M Hughes
Journal:  Infect Control       Date:  1985-02

7.  Molecular structure and immunity specificity of colicin E6, an evolutionary intermediate between E-group colicins and cloacin DF13.

Authors:  A Akutsu; H Masaki; T Ohta
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

8.  Characterization of bacterial etiologic agents of biofilm formation in medical devices in critical care setup.

Authors:  Sangita Revdiwala; Bhaumesh M Rajdev; Summaiya Mulla
Journal:  Crit Care Res Pract       Date:  2012-01-24

9.  Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.

Authors:  Ørjan Samuelsen; Søren Overballe-Petersen; Jørgen Vildershøj Bjørnholt; Sylvain Brisse; Michel Doumith; Neil Woodford; Katie L Hopkins; Bettina Aasnæs; Bjørg Haldorsen; Arnfinn Sundsfjord
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

10.  Validation of biofilm formation on human skin wound models and demonstration of clinically translatable bacteria-specific volatile signatures.

Authors:  Mohammed Ashrafi; Lilyann Novak-Frazer; Matthew Bates; Mohamed Baguneid; Teresa Alonso-Rasgado; Guoqing Xia; Riina Rautemaa-Richardson; Ardeshir Bayat
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

View more
  2 in total

1.  High-Resolution Genomic Profiling of Carbapenem-Resistant Klebsiella pneumoniae Isolates: A Multicentric Retrospective Indian Study.

Authors:  Geetha Nagaraj; Varun Shamanna; Vandana Govindan; Steffimole Rose; D Sravani; K P Akshata; M R Shincy; V T Venkatesha; Monica Abrudan; Silvia Argimón; Mihir Kekre; Anthony Underwood; David M Aanensen; K L Ravikumar
Journal:  Clin Infect Dis       Date:  2021-12-01       Impact factor: 9.079

2.  SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant Klebsiella pneumoniae, Its Biofilms, and Persister Cells.

Authors:  Pengfei She; Yaqian Liu; Lanlan Xu; Yimin Li; Zehao Li; Shasha Liu; Zubair Hussain; Yong Wu
Journal:  Front Cell Infect Microbiol       Date:  2022-03-18       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.